BNET Industries
Boston Scientific Corp. (BSX) is in the Health Care Industry
- Revenue
- Dec 31 2007
- $8.3B
- Profit
- Dec 31 2007
- ($495.0M)
- Market Cap
- Aug 19 2008
- $19.1B
Latest News and Analysis
Boston Scientific Corp. Q2 2008 Earnings Call Transcript
Boston Scientific Corporation BSX Q2 FY08 Earnings Call
Boston Scientific Corp. Q2 2008 Earnings Call Transcript
Boston Scientific Corporation BSX Q2 FY08 Earnings Call
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q1 2008 Earnings Call Transcript
Boston Scientific Corp. Q4 2007 Earnings Call Transcript
Boston Scientific Corp. Q4 2007 Earnings Call Transcript
Boston Scientific Q3 2007 Earnings Call Transcript
Boston Scientific Q3 2007 Earnings Call Transcript
Boston Scientific Q2 2007 Earnings Call Transcript
Boston Scientific Q2 2007 Earnings Call Transcript
Additional Resources
Navilyst Medical Announces Global Debut Today
Former Boston Scientific Business Units Combine to Lead Fluid Management and Vascular Access Markets MARLBOROUGH, Mass. -- Navilyst Medical, formerly Boston Scientific's Fluid Management and Vascular Access businesses, today announced its new company name following the February 2008 acquisition by Avista Capital Partners, a private equity firm focused...
Medtech Insight/Windhover Information's "Medical Device Investor Day" Symposium to Feature Presentations by 3M, B. Braun, BD, Boston Scientific, Covidien, Ethicon/J&J, Medtronic and Stryker, Among Others
October 22, 2008, Boston, MA IRVINE, Calif. -- Medtech Insight, a division of FDC/Windhover and Reed Elsevier and a leading provider of business information for the medical device industry, has announced that its first-of-its-kind "Medical Device Investor Day" symposium on October 22nd in Boston, MA, will feature illuminating...
DeviceSpace™ to Host Medical Device and Diagnostics Career Fair in Minneapolis
Medical Device and Diagnostics Event Expected to Attract a Record Number of Jobseekers MANASQUAN, N.J., July 29 /PRNewswire/ -- DeviceSpaceTM, the world's leading online medical device and diagnostics job board and career fair company, will host the DeviceSpace Career Fair in Minneapolis, Minnesota on Monday, September 8,...
Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer
LEXINGTON, Mass., July 24 /PRNewswire/ -- Tepha, Inc., a developer of medical devices derived from a new class of resorbable polymers, announced today that it has appointed John Hartnett to the new position of Executive Vice President and Chief Operating Officer. Mr. Hartnett joins Tepha following an eighteen...
Antisoma appoints Michael Lewis as a Non-Executive Director
9 July 2008 London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) todayannounces the appointment of Mr Michael Lewis as a Non-ExecutiveDirector with immediate effect. Mr Lewis is currently President for Europe, Middle East and Africaand was also Head of Global Marketing for the medical device companyGambro, with responsibility...
Research and Markets: A Performance Analysis of Johnson & Johnson in the Ethical Pharmaceutical Sector: Including a Six Year Sales Forecast and Competitor Profiling
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/a3817c/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio...
Medtech Insight and FDC/Windhover Announce their Upcoming "Medical Device Investor Day" Symposium and "Investment In Innovation East" Conference
October 22-24, 2008, Boston, MA NEWPORT BEACH, Calif. -- Medtech Insight, a division of FDC/Windhover and Reed Elsevier and a leading provider of business information for the medical device industry, will host a first-of-its-kind "Medical Device Investor Day" symposium, followed immediately by their "Investment In...
Joe Hallow Named to the Board of Directors of BridgePoint Medical, LLC
LEXINGTON, Ky., July 8 /PRNewswire/ -- BridgePoint Medical, LLC, an independently owned prosthetic and orthotic company, today announced that Joseph F. Hallow, III has been elected to serve on its Board of Directors. Mr. Hallow currently serves as president of Bissell Hotels in Charlotte, North Carolina....
Syndicated Radio Host Mel Robbins to Broadcast Advice and Interview Show Live from Borders® in Downtown Crossing, Boston
First Guest in Robbins' New Borders Radio Booth is Bestselling Author Dennis Lehane ANN ARBOR, Mich., July 8 /PRNewswire-FirstCall/ -- BordersR and Advice for Living Inc. are excited to announce that "Make It Happen" -- a nationally syndicated radio program hosted by respected life...
Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/9cbe1a/australia_cardiova) has announced the addition of the "Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering. Australia Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 Summary: This report is...
Argentina Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 is out Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/fece95/argentina_cardiova) has announced the addition of the "Argentina Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering. Argentina Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 Summar: This report is...
Understand the Brazilian Cardiovascular Devices Market by Examining the Latest Investment Opportunities, Analysis and Forecasts to 2012
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/47640e/brazil_cardiovascu) has announced the addition of the "Brazil Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012" report to their offering. Brazil Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 This report is an essential source...
Spectranetics Appoints Michael Voss as Vice President and General Manager of Vascular Intervention Business
COLORADO SPRINGS, Colo. -- Spectranetics Corporation (Nasdaq:SPNC) today announced it has appointed Michael J. Voss as its Vice President and General Manager, Vascular Intervention VI. Mr. Voss has over 15 years of experience in the medical device business with a broad sales and marketing background....
- Next »
- page 1 of 1
- « Previous
Sort byClose
View Related Content by Tag Close
- Incorporated: 1979
- CEO: Mr. James R. Tobin
Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a variety of interventional medical specialties including interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation. Co.'s products are offered for sale mainly by three business groups: Cardiovascular, which includes its interventional cardiology, cardiac rhythm management and cardiovascular divisions; Endosurgery, which includes its oncology, endoscopy and urology/gynecology divisions; and Neuromodulation, which includes its auditory and pain management divisions.
Key Competitors
Boston Scientific Corp. Company Info
Board of Directors
Mr. Peter M. Nicholas
Chairman
Mr. James R. Tobin
Mr. John E. Abele
Mr. Joel L. Fleishman
Dr. Kristina M. Johnson Ph.D.
Dr. Ernest Mario Ph.D.
Dr. Uwe E. Reinhardt
Ms. Ursula M. Burns
Ms. Nancy-Ann DeParle
Mr. J. Raymond Elliott
Dr. Marye Anne Fox Ph.D.
Mr. Ray J. Groves
Mr. N. J. Nicholas Jr.
Mr. John E. Pepper Jr.
Senator Warren B. Rudman
Contact Information
One Boston Scientific Place
Natick, MA
508 650-8000
